548 related articles for article (PubMed ID: 25048361)
1. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
2. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Reinert S
Acta Odontol Scand; 2015 Jul; 73(5):336-42. PubMed ID: 25234444
[TBL] [Abstract][Full Text] [Related]
4. Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?
Grimm M; Calgéer B; Teriete P; Biegner T; Munz A; Reinert S
Clin Transl Oncol; 2016 Feb; 18(2):196-205. PubMed ID: 26179749
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of T-type calcium channel Cav3.1 in oral squamous cell carcinoma: association with proliferation and anti-apoptotic activity.
Li RF; Man QW; Liu JY; Zheng YY; Gao X; Liu HM
J Mol Histol; 2021 Jun; 52(3):511-520. PubMed ID: 33394292
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
7. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
8. The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells.
Kurihara-Shimomura M; Sasahira T; Nakashima C; Kuniyasu H; Shimomura H; Kirita T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257458
[TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.
Grimm M; Cetindis M; Biegner T; Lehman M; Munz A; Teriete P; Reinert S
Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e188-95. PubMed ID: 25662556
[TBL] [Abstract][Full Text] [Related]
10. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
11. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
12. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
13. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
14. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
15. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
[TBL] [Abstract][Full Text] [Related]
16. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
17. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
Meng Z; Wang Y; Wang X; Han X
Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
[TBL] [Abstract][Full Text] [Related]
18. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
19. MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production.
Xiao T; Sun J; Xing Z; Xie F; Yang L; Ding W
Cell Biol Int; 2020 Mar; 44(3):821-829. PubMed ID: 31814213
[TBL] [Abstract][Full Text] [Related]
20. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]